全球更年期治療市場：依治療類型、給藥途徑、劑型、適應症、通路及地區分類

全球更年期治療市場預計到 2026 年將達到 161.9 億美元，預計到 2033 年將達到 248.3 億美元。預計從 2026 年到 2033 年，該市場將以 6.3% 的複合年成長率成長。

更年期是女性通常經歷的自然生理過程，一般發生在45至55歲之間。它標誌著女性生育期的結束和向停經後生活的過渡。更年期最常見的徵兆和症狀包括月經不規則、潮熱、盜汗、陰道乾澀、情緒波動和睡眠障礙。隨著更年期的進展，女性體內的雌激素水平會急劇下降，如果不加以治療，可能會導致多種長期健康風險。因此，在這段過渡時期，如何有效控制更年期症狀已成為許多女性的首要任務。全球更年期治療市場為受更年期症狀困擾的女性提供了多種治療選擇。

市場動態：

生活方式的改變和健康意識的提高導致女性更年期症狀的日益普遍，這是全球更年期治療市場成長的主要因素。大量研究表明，約四分之一的40至60歲女性至少經歷一種與更年期相關的症狀。久坐工作增加和缺乏體能活動也會增加過早閉經的風險。此外，大型製藥企業批准並推出新產品，也為解決更年期血管舒縮症狀提供了更多治療選擇。然而，荷爾蒙補充療法的副作用以及其他療法的存在，在某種程度上仍然限制了市場的發展潛力。此外，開發中國家對治療的認知度較低，也為市場相關人員帶來了挑戰。儘管如此，亞太地區更年期護理技術的進步和醫療旅遊的蓬勃發展，預計將在未來幾年為相關人員帶來巨大的商機。

本研究的主要特點：

• 這項研究揭示了各個細分市場的潛在成長機會，並為該市場說明了一個有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數介紹了全球更年期治療市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份「全球更年期治療市場」報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過對全球更年期治療市場進行分析時所使用的各種策略矩陣，相關人員將能夠做出更順利的決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 新產品發布
  • 老年人口增加
  • 透過資金籌措和投資提供財務支持
• 影響分析
• 主要亮點
• 市場趨勢
• PEST分析
• 監管趨勢
• 併購和合作
• 主要服務內容
• 治療成本分析
• 識別主要公司
• 政府措施和投資
• 品牌定位與定價分析
• 各國醫療保健成本

第4章 全球更年期治療市場：依治療類型分類，2021-2033年

• 荷爾蒙療法
• 非荷爾蒙療法
• 其他

第5章 全球更年期治療市場：依給藥途徑分類，2021-2033年

• 口服
• 外用
• 腸外
• 陰道內部
• 其他

第6章 全球更年期治療市場：依劑型分類，2021-2033年

• 藥片
• 奶油
• 修補
• 子宮托
• 注射藥物
• 其他

第7章 全球更年期治療市場：依適應症分類，2021-2033年

• 閉經
• 停經
• 停經後

第8章 全球更年期治療市場：依通路分類，2021-2033年

• 醫院藥房
• 零售藥房
• 網路藥房
• 專賣店
• 其他

第9章 全球更年期治療市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第10章 競爭格局

• 公司簡介
  • Novartis AG
  • Pfizer Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Novo Nordisk A/S
  • illendo Therapeutics, Inc.
  • Mithra Pharmaceuticals
  • Merck & Co., Inc
  • Cipla Inc.
  • Abbott
  • Viatris Inc.
  • Organon
  • SnapNurse
  • Glenmark Pharmaceuticals Limited
  • Procter & Gamble
  • Duchesnay USA.
  • TherapeuticsMD, Inc.
  • Avion Pharmaceuticals
  • KWS
  • PharmaCare Europe Ltd.
  • Amneal Pharmaceuticals LLC.
• 分析師意見

第11章

• 參考
• 調查方法
• 關於本公司

Global Menopause Treatment Market is estimated to be valued at USD 16.19 Bn in 2026 and is expected to reach USD 24.83 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.

Menopause is a natural biological process that usually occurs between the ages of 45 to 55 years in women. It marks the end of a woman's reproductive years and the transition into her post-reproductive life. Some of the most common signs and symptoms of menopause include irregular menstrual periods, hot flashes, night sweats, vaginal dryness, mood changes, and difficulty sleeping. As menopause progresses, a woman's estrogen levels drop dramatically, which could lead to several long-term health risks if left untreated. Therefore, managing symptoms during this transitional phase has become a priority for many women. The global menopause treatment market offers a variety of treatment options for women suffering from menopause symptoms.

Market Dynamics:

The rising prevalence of menopause issues among women owing to changing lifestyle patterns and growing health awareness levels is a key factor driving the growth of global menopause treatment market. Numerous researches have shown that approximately one-fourth of women within the age group of 40 to 60 years report experiencing at least one problematic symptom associated with menopause. There is also the emergence of sedentary jobs and a lack of physical activity, which has escalated the risks of premature or early menopause. Additionally, new product approvals and launches by leading pharmaceutical players are expanding the treatment choices for addressing vasomotor symptoms during menopause. However, side effects associated with hormone replacement therapy and the availability of alternative treatment options still limit the market potential to a certain extent. Moreover, a lack of awareness about treatment in developing nations poses a challenge to market players. Nonetheless, technological advancements in menopausal care and growing medical tourism in the Asia Pacific region are expected to unlock lucrative opportunities for stakeholders in coming years.

Key Features of the Study:

• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global menopause treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novo Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck & Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organon, SnapNurse, Glenmark Pharmaceuticals Limited, Procter & Gamble, Duchesnay USA., TherapeuticsMD, Inc., Avion Pharmaceuticals, KWS, PharmaCare Europe Ltd., Amneal Pharmaceuticals LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global menopause treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menopause treatment market

Detailed Segmentation:

• Global Menopause Treatment Market, By Treatment Type (Revenue, USD Bn, 2021 - 2033)
• Hormone Therapy
  • Estrogen-based Drugs
  • Progestin-based Drugs
  • Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
• Non-hormonal Therapy
  • Neurokinin 3 (NK3)
  • Receptor Antagonist
  • Selective Serotonin
  • Reuptake Inhibitor (SSRI)
  • Others
• Others
• Global Menopause Treatment Market, By Route of Administration (Revenue, USD Bn, 2021 - 2033)
• Oral
• Topical
• Parenteral
• Vaginal
• Others
• Global Menopause Treatment Market, By Form (Revenue, USD Bn, 2021 - 2033)
• Tablets
• Creams
• Patches
• Pessaries
• Injections
• Others
• Global Menopause Treatment Market, By Indication (Revenue, USD Bn, 2021 - 2033)
• Perimenopause
• Menopause
• Postmenopause
• Global Menopause Treatment Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Specialty Stores
• Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Top Companies in the Global Menopause Treatment Market:
• Novartis AG
• Pfizer Inc.
• Bayer AG
• Teva Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Novo Nordisk A/S
• illendo Therapeutics, Inc.
• Mithra Pharmaceuticals
• Merck & Co., Inc
• Cipla Inc.
• Abbott
• Viatris Inc.
• Organon
• Glenmark Pharmaceuticals Limited
• Procter & Gamble
• Duchesnay USA.
• TherapeuticsMD, Inc.
• Avion Pharmaceuticals
• KWS
• PharmaCare Europe Ltd.
• Amneal Pharmaceuticals LLC.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Treatment Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Form
  • Market Snippet, By Indication
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • New Product Launches
  • Rising Geriatric Population
  • Financial Support Through Funding And Investments
• Impact Analysis
• Key Highlights
• Market Trends
• PEST Analysis
• Regulatory Scenario
• Mergers, Acquisitions, and Collaborations
• Key Services Offered
• Treatment cost Analysis
• Identification of Top Market Players
• Government Initiatives and Investments
• Brand Mapping & Pricing Analysis
• Healthcare Spending by Country

4. Global Menopause Treatment Market, By Treatment Type, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hormone Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Estrogen-based Drugs
    • Progestin-based Drugs
    • Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
• Non-hormonal Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Neurokinin 3 (NK3)
    • Receptor Antagonist
    • Selective Serotonin
    • Reuptake Inhibitor (SSRI)
    • Others
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Global Menopause Treatment Market, By Route of Administration, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Vaginal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Menopause Treatment Market, By Form, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Tablets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Creams
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Pessaries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Injections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Menopause Treatment Market, By Indication, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Perimenopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Menopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Postmenopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Menopause Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Specialty Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

9. Global Menopause Treatment Market, By Region, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region/Country, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region/Country, 2022 - 2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novo Nordisk A/S
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • illendo Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Mithra Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & Co., Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cipla Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Viatris Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Organon
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SnapNurse
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Glenmark Pharmaceuticals Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Procter & Gamble
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Duchesnay USA.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • TherapeuticsMD, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Avion Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • KWS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • PharmaCare Europe Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Amneal Pharmaceuticals LLC.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
• Analyst Views

11. Section

• References
• Research Methodology
• About us